Cannara Biotech, Inc.
No trades
No trades
Price target
3.380.000.00%
The 4 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 4 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.
Frequently asked questions
The current price of LOVE is 1.98 CAD — it hasn't changed in the past 24 hours. Watch Cannara Biotech, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange Cannara Biotech, Inc. stocks are traded under the ticker LOVE.
LOVE stock has risen by 4.21% compared to the previous week, the month change is a 4.21% rise, over the last year Cannara Biotech, Inc. has showed a 3.66% increase.
We've gathered analysts' opinions on Cannara Biotech, Inc. future price: according to them, LOVE price has a max estimate of 4.00 CAD and a min estimate of 3.00 CAD. Watch LOVE chart and read a more detailed Cannara Biotech, Inc. stock forecast: see what analysts think of Cannara Biotech, Inc. and suggest that you do with its stocks.
LOVE reached its all-time high on Jul 5, 2021 with the price of 18.50 CAD, and its all-time low was 0.52 CAD and was reached on Jul 12, 2024. View more price dynamics on LOVE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LOVE stock is 0.76% volatile and has beta coefficient of 0.49. Track Cannara Biotech, Inc. stock price on the chart and check out the list of the most volatile stocks — is Cannara Biotech, Inc. there?
Today Cannara Biotech, Inc. has the market capitalization of 195.59 M, it has increased by 1.61% over the last week.
Yes, you can track Cannara Biotech, Inc. financials in yearly and quarterly reports right on TradingView.
Cannara Biotech, Inc. is going to release the next earnings report on Nov 24, 2026. Keep track of upcoming events with our Earnings Calendar.
LOVE earnings for the last quarter are 0.05 CAD per share, whereas the estimation was 0.05 CAD resulting in a 0.00% surprise. The estimated earnings for the next quarter are 0.04 CAD per share. See more details about Cannara Biotech, Inc. earnings.
Cannara Biotech, Inc. revenue for the last quarter amounts to 31.29 M CAD, despite the estimated figure of 31.23 M CAD. In the next quarter, revenue is expected to reach 34.41 M CAD.
LOVE net income for the last quarter is 4.84 M CAD, while the quarter before that showed 1.66 M CAD of net income which accounts for 0.00% change. Track more Cannara Biotech, Inc. financial stats to get the full picture.
No, LOVE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 16, 2026, the company has 452 employees. See our rating of the largest employees — is Cannara Biotech, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cannara Biotech, Inc. EBITDA is −1.54 M CAD, and current EBITDA margin is −1.19%. See more stats in Cannara Biotech, Inc. financial statements.
Like other stocks, LOVE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cannara Biotech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cannara Biotech, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cannara Biotech, Inc. stock shows the buy signal. See more of Cannara Biotech, Inc. technicals for a more comprehensive analysis.